CD97 maintains tumorigenicity of glioblastoma stem cells via mTORC2 signaling and is targeted by CAR Th9 cells

Shuchang Zhou(Henan University), Jinlong Yin(Henan University)
Cell Reports Medicine
December 1, 2024
Cited by 14


Related Papers